Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
National Institutes of Health (NIH) officials discuss scientific evidence and principles underlying the U=U concept.
The new federal initiative will work with existing research programs in eight cities.
Periodic infusions of such antibodies may eventually become a new way of treating the virus.
The iconic AIDS activist sounded off in a STAT interview—and shared how he’s spending his declining years.
Promising news on the prevention front
It’s the NIH’s first large-scale clinical trial on the subject. Plus: Meet organ transplant advocate Mo Murray [VIDEO].
With a grant to follow their large study population through 2021, researchers hope to gain vital new insights about HIV infection.
Three antibodies combined into one protected monkeys against a simian version of HIV, opening the door for human trials.
Courting controversy, the NIH considers a shift away from the development of new vaginal or rectal-based HIV prevention products.
A statement from the National Institutes of Health on World AIDS Day 2017.
The study of a vaccine that is designed to prevent multiple strains of the virus will include 2,600 women in sub-Saharan Africa.
HIV scientists and advocates are waging a powerful war against the global epidemic.
A 9-year-old South African child infected with HIV at birth has been in an apparent state of extended viral remission.
A new HIV vaccine regimen was well tolerated and elicited a good immune response among participants of a study who did not have the virus.
Researchers found a way to block a protein linked with blood clotting and inflammatory processes using a drug derived from tick saliva.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.